-
The president says the actions will lower drug prices, but policy experts say they will likely offer patients only minimal relief and may take months to implement, if they're implemented at all.
-
John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.
-
Dozens of patient advocacy groups, like the Bonnie J. Addario Lung Cancer Foundation and the National Coalition for Cancer Survivorship, recently appeared…
-
Alex Azar’s job hop from drug-maker Eli Lilly to the Trump administration reflects ever-deepening ties between the pharmaceutical industry and the federal…